SCHEMBL8809501

SCHEMBL8809501

c1cc(CNC2CCCC2)cc(-c2cc[nH]n2)c1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.52
▸ MAP4K4 O95819 5/20 0.52
▸ PARP1 P09874 5/20 0.51
▸ KCNH2 Q12809 1/20 0.51
▸ POLB P06746 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ PKM P14618 1/20 0.45
▸ HRH3 Q9Y5N1 1/20 0.44
▸ PRKD1 Q15139 1/20 0.43
▸ CXCR4 P61073 1/20 0.43
▸ CARM1 Q86X55 1/20 0.41
▸ PRMT6 Q96LA8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8809463 0.99 ALDH1A1 (0.51) ALDH1A1MAP4K4PARP1KCNH2POLB
SCHEMBL8809605 0.99 ALDH1A1 (0.51) ALDH1A1MAP4K4PARP1KCNH2POLB
SCHEMBL8808822 0.82 HRH3 (0.64) ALDH1A1PARP1POLBKDM4EPKM
SCHEMBL18984688 0.77 MAP4K4 (0.56) ALDH1A1MAP4K4PARP1KCNH2POLB
SCHEMBL9057097 0.77 MAP4K4 (0.53) ALDH1A1MAP4K4PARP1KCNH2POLB
SCHEMBL8807206 0.77 MAP4K4 (0.50) ALDH1A1MAP4K4PARP1KCNH2POLB
SCHEMBL8811307 0.76 BCHE (0.45) ALDH1A1KDM4EHRH3
SCHEMBL8807848 0.76 HRH3 (0.62) ALDH1A1MAP4K4PARP1KCNH2POLB
SCHEMBL8809953 0.75 PARP1 (0.53) ALDH1A1MAP4K4PARP1KCNH2POLB
SCHEMBL8811233 0.75 KCNH2 (0.56) ALDH1A1MAP4K4PARP1KCNH2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0784612-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-07-23 — — EP disclosed
WO-1996010559-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-11 — — WO disclosed
Send feedback